GP
WX

GLG Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

GLG Partners’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-687,093
Closed -$29.7M – 570
2015
Q3 		$29.7M Buy
+687,093
New +$29M 0.78% 27

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

GLG Partners's WX Position: Q4 2015 in Review

GLG Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 687,093 shares — an estimated $29.7M sold.

GLG Partners first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $29.7M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • GLG Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • GLG Partners sold 687,093 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $29.7M.
  • GLG Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • GLG Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $29.7M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on GLG Partners's 13F filing for Q4 2015, filed 16 Feb 2016.